Miqcort-200 combines Formoterol Fumarate and Budesonide Powder for Inhalation IP, used to manage asthma and chronic obstructive pulmonary disease (COPD). Formoterol, a long-acting beta agonist, relaxes airway muscles, improving airflow. Budesonide, a corticosteroid, reduces airway inflammation. This combination medication helps prevent asthma attacks and COPD exacerbations. It is prescribed for long-term maintenance therapy. Follow the prescribed dosage regimen for effective management of respiratory conditions.Available in PCD pharma franchise and Third Party manufacturing in saturn formulations